Camurus Reduces Case Processing Time and Costs with In-House Safety
Camurus, a Swedish biotech, wanted greater control over pharmacovigilance rather than outsourcing it, and implemented Veeva Safety and SafetyDocs to manage case processing internally. The page states this brought at least a 30-minute reduction in case processing time per case while maintaining compliance, along with reduced associated costs from the move to in-house safety management.
Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Veeva Systems on its own site — read the original case study on veeva.com ↗
Related use cases
- 01Transforming Content Operations for 2x Faster Time to Market
- 02Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 03How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 04Reaching Underserved Communities with Smarter Targeting
- 05Building Agile Territory Strategies to Scale Pre-Commercial Field Teams
- 06How Alfasigma Unified Regulatory Data and Processes for Cross-Functional Alignment